Journal of the American Chemical Society
ARTICLE
112.2, 110.5, 91.3, 89.8, 81.8, 21.0. HRMS (ESI+) Calcd for [M + H],
542.12398; Found, 542.12316 (À0.82 mmu).
125.1, 124.0, 112.7, 108.5, 102.3. HRMS(ESIÀ) Calcd for [M À H],
508.06686; Found, 508.07060 (3.74 mmu).
9: 1H NMR (300 MHz, CDCl3) δ 8.25 (dt, 2H, J = 8.79, 2.11 Hz),
8.20 (dd, 1H, J = 1.28, 0.79 Hz), 7.84 (dd, 1H, J = 8.07, 1.47 Hz), 7.72 (dt,
2H, J = 8.79, 2.11 Hz), 7.22 (dd, 1H, J = 7.98, 0.64 Hz), 7.11 (t, 2H, J = 1.38
Hz), 6.85 (m, 4H). 13C NMR (75 MHz, CDCl3) δ 168.8, 167.9, 152.9,
152.2, 151.5, 147.5, 138.3, 132.5, 129.1, 128.8, 128.4, 126.7, 124.6, 124.4,
123.8, 117.9, 115.8, 110.5, 92.1, 89.6, 81.8, 21.1. HRMS (ESI+) Calcd for
[M + Na], 584.09575; Found, 584.09197 (À3.78 mmu).
Synthesis of NBzFDA. 9 (20.1 mg, 0.0358 mmol) was dissolved in
1 mL of DMSO, and PdCl2 (0.65 mg, 3.67 μmol) was added. The
mixture was stirred at 145 °C for 4 h under an Ar atmosphere and
purified by preparative HPLC to afford NBzFDA (11.0 mg, 52%) as a
slightly yellow solid. 1H NMR (300 MHz, DMSO-d6) δ 8.60 (s, 1H),
8.44 (m, 1H), 8.42 (m, 2H), 8.30 (d, 2H, J = 8.79 Hz), 7.69 (d, 1H,
J = 8.04 Hz), 7.32 (d, 2H, J = 1.47 Hz), 7.00 (d, 2H, J = 8.76 Hz), 6.97 (dd,
2H, J = 8.79, 2.22 Hz), 2.30 (s, 6H). 13C NMR (75 MHz, DMSO-d6)
190.5, 190.2, 168.7, 157.0, 152.3, 150.8, 137.0, 134.2, 131.7, 129.3, 127.3,
126.3, 125.2, 124.0, 118.7, 115.2, 110.6, 81.4, 20.8. HRMS (ESI+) Calcd
for [M + Na], 616.08558; Found, 616.08239 (À3.18 mmu).
Synthesis of 1. 5 (51.6 mg, 0.100 mmol) was dissolved in 2 mL of
DMSO, and PdCl2 (4.95 mg, 0.0279 mmol) was added to the solution.
The reaction mixture was stirred at 105 °C for 12 h under an Ar
atmosphere. Then, 2 mL of methanol and K2CO3 (100 mg) were added,
and the mixture was stirredat25 °C for 10 min. Purification bypreparative
HPLC afforded 1 (19.2 mg, 41%) as a yellow solid. 1H NMR (300 MHz,
CD3OD) δ 8.53 (s, 1H), 8.35 (dd, 1H, J = 8.07 Hz), 8.05 (d, 2H, J = 7.70
Hz), 7.76 (t, 1H, J = 7.43 Hz), 7.61 (t, 2H, J = 7.70 Hz), 7.43 (d, 1H,
J = 7.89 Hz), 6.73 (d, 2H, J = 2.02 Hz), 6.69 (d, 2H, J = 8.99 Hz), 6.58 (dd,
2H, J = 8.62, 2.20 Hz). 13C NMR (75 MHz, CD3OD) δ 194.9, 193.9,
169.6, 162.4, 154.5, 136.9, 136.5, 136.0, 134.0, 131.1, 130.5, 130.4, 129.4,
128.1, 127.0, 114.4, 110.9, 103.6. HRMS (ESIÀ) Calcd for [M À H],
463.08178; Found, 463.07858 (À3.20 mmu).
’ ASSOCIATED CONTENT
S
Supporting Information. Detailed absorbance and fluor-
b
escence changes of NBzF upon addition of various ROS; HPLC
analysis of the reaction product of NBzF with various ROS;
Fluorescence response of 1À4 to various ROS; NMR spectral
analysis of the reaction of NBzF and hydrogen peroxide; Kinetic
traces of NBzF and hydrogen peroxide; Full information of ref 9.
This material is available free of charge via the Internet at http://
pubs.acs.org.
2, 3, and 4 were similarly prepared from 6, 7, and 8 in 57%, 41%, and
48% yield, respectively.
2: 1H NMR (300 MHz, CD3OD) δ 8.43 (d, 1H, J = 0.75 Hz), 8.26
(dd, 1H, J = 7.86, 1.47 Hz), 7.87 (d, 2H, J = 8.61 Hz), 7.70 (d, 2H, J =
8.61 Hz), 7.31 (d, 1H, J = 8.04 Hz), 6.60 (d, 2H, J = 2.22 Hz), 6.54
(d, 2H, J = 8.61 Hz), 6.45 (dd, 2H, J = 8.79, 2.40 Hz). 13C NMR (100 MHz,
DMSO-d6) δ 192.1, 191.7, 167.5, 159.8, 157.8, 151.7, 136.4, 133.8,
132.5, 132.0, 131.1, 130.1, 129.3, 127.0, 126.6, 125.3, 112.8, 108.5, 102.3,
83.5. HRMS (ESIÀ) Calcd for [M À H], 540.99229; Found, 540.98767
(À4.62 mmu).
’ AUTHOR INFORMATION
Corresponding Author
’ ACKNOWLEDGMENT
3: 1H NMR (300 MHz, DMSO-d6) δ 10.2 (s, 2H), 8.34 (s, 1H), 8.27
(dd, 1H, J = 8.07, 1.29 Hz), 8.00 (d, 2H, J = 8.97 Hz), 7.49 (d, 1H, J =
8.04 Hz), 7.16 (d, 2H, J = 8.79 Hz), 6.70 (d, 2H, J = 2.19 Hz), 6.65 (d,
2H, J = 8.61 Hz), 6.53 (dd, 2H, J = 8.61, 2.19 Hz), 3.89 (s, 3H). 13C
NMR (100 MHz, DMSO-d6) δ 193.0, 192.0, 167.4, 165.18, 159.8, 151.8,
136.1, 134.1, 132.6, 129.3, 127.2, 126.1, 125.4, 124.9, 114.9, 112.7, 108.5,
102.3, 55.9. HRMS (ESIÀ) Calcd for [M À H], 493.09234; Found,
493.08791 (À4.43 mmu).
This work was supported in part by a Grant-in-Aid for JSPS
Fellows (to M.A.), by a Grant-in-Aid for Specially Promoted
Research No. 22000006 to T.N., by the Ministry of Education,
Culture, Sports, Science and Technology of Japan (Grant Nos.
19205021 and 20117003 to Y.U., 20689001 and 21659204 to K.H.,
and 21750135 to T.T.), and by the Industrial Technology Research
Grant Program in 2009 for the New Energy and Industrial Techno-
logy Development Organization (NEDO) of Japan (to T.T.). K.H.
was also supported by the Sankyo Foundation of Life Science.
4: 1H NMR (300 MHz, DMSO-d6) δ 10.1 (s, 2H), 8.50 (m, 1H), 8.37
(d, 1H, J = 8.07 Hz), 8.20 (d, 2H, J = 8.25 Hz), 8.10 (d, 2H, J = 8.07 Hz),
7.51 (d, 1H, J = 8.04 Hz), 6.69 (d, 2H, J = 1.65 Hz), 6.63 (d, 2H, J = 8.61
Hz), 6.54 (dd, 2H, J = 8.79, 1.65 Hz). 13C NMR (100 MHz, DMSO-d6)
δ 191.2, 190.7, 167.5, 159.8, 157.8, 151.8, 136.7, 135.5, 133.8, 133.0,
130.8, 129.3, 127.0, 126.9, 125.1, 118.0, 116.8, 112.8, 108.5, 102.3.
HRMS (ESIÀ) Calcd for [M À H], 488.07703; Found, 488.07359
(À3.43 mmu).
’ REFERENCES
(1) (a) Finkel, T. Curr. Opin. Cell Biol. 2003, 15, 247–254. (b) Valko,
M.; Leibfritz, D.; Moncol, J.; Cronin, M. T.; Mazur, M.; Telser, J. Int. J.
Biochem. Cell Biol. 2007, 39, 44–84. (c) D’Autreaux, B.; Toledano, M. B.
Nat. Rev. Mol. Cell Biol. 2007, 8, 813–824.
(2) Hansson, G. K.; Libby, P. Nat. Rev. Immunol. 2006, 6, 508–519.
(3) Seitz, H. K.; Stickel, F. Nat. Rev. Cancer 2007, 7, 599–612.
(4) Galluzzi, L.; Blomgren, K.; Kroemer, G. Nat. Rev. Neurosci. 2009,
10, 481–494.
(5) Matsuzawa, A.; Saegusa, K.; Noguchi, T.; Sadamitsu, C.; Nishitoh,
H.; Nagai, S.; Koyasu, S.; Matsumoto, K.; Takeda, K.; Ichijo, H. Nat.
Immunol. 2005, 6, 587–592.
(6) Li, Q.; Harraz, M. M.; Zhou, W.; Zhang, L. N.; Ding, W.; Zhang,
Y.; Eggleston, T.; Yeaman, C.; Banfi, B.; Engelhardt, J. F. Mol. Cell. Biol.
2006, 26, 140–154.
Synthesis of NBzF. 9 (58.0 mg, 0.103 mmol) was dissolved in 3 mL
of dichloromethane and 3 mL of methanol. Potassium carbonate
(62.9 mg, 0.456 mmol) was added. The mixture was stirred at 25 °C
for 60 min and then concentrated, and the resulting solid was dissolved
in sat. NaHCO3 aq. The water layer was washed with dichloromethane,
acidified with 2 N HCl aq., and extracted with ethyl acetate. The organic
layer was washed with brine, dried over Na2SO4, and concentrated to
afford 48.0 mg of an orange solid. The orange solid (19.8 mg) was
dissolved in 0.5 mL of DMSO, and PdCl2 (0.72 mg, 4.07 μmol) was
added. The mixture was stirred at 145 °C for 4 h under an Ar atmosphere
and then purified by preparative HPLC to afford NBzF (10.8 mg, 51%)
as a yellow solid. 1H NMR (300 MHz, CD3OD) δ 8.60 (s, 1H), 8.46 (m,
1H), 8.41 (m, 2H), 8.32 (d, 2H, J = 8.90 Hz), 7.43 (d, 1H, J = 8.04 Hz),
6.70 (d, 2H, J = 2.19 Hz), 6.64 (d, 2H, J = 8.79 Hz), 6.55 (dd, 2H, J =
8.79, 2.19 Hz). 13C NMR (100 MHz, DMSO-d6) δ 190.7, 190.3, 167.4,
159.7, 157.7, 151.7, 150.8, 136.9, 136.7, 133.8, 131.7, 129.2, 127.0, 126.8,
(7) Winterbourn, C. C. Nat. Chem. Biol. 2008, 4, 278–286.
(8) Rhee, S. G. Science 2006, 312, 1882–1883.
(9) Capasso, M.; et al. Nat. Immunol. 2010, 11, 265–272.
(10) Funato, Y.; Michiue, T.; Asashima, M.; Miki, H. Nat. Cell Biol.
2006, 8, 501–508.
(11) Kamata, H.; Honda, S.; Maeda, S.; Chang, L.; Hirata, H.; Karin,
M. Cell 2005, 120, 649–661.
10636
dx.doi.org/10.1021/ja203521e |J. Am. Chem. Soc. 2011, 133, 10629–10637